Authors: Capparelli, EV Sullivan, JL Mofenson, L Smith, E Graham, B Britto, P Becker, MI Holland, D Connor, JD Luzuriaga, K

Citation: Ev. Capparelli et al., Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants, PEDIAT INF, 20(8), 2001, pp. 746-751

Authors: Scott, ZA Chadwick, EG Gibson, LL Catalina, MD McManus, MM Yogev, R Palumbo, P Sullivan, JL Britto, P Gay, H Luzuriaga, K

Citation: Za. Scott et al., Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants, J IMMUNOL, 167(12), 2001, pp. 7134-7140

Authors: Shapiro, DE Sperling, RS Mandelbrot, L Britto, P Cunningham, BE

Citation: De. Shapiro et al., Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis, OBSTET GYN, 94(6), 1999, pp. 897-908

Authors: Luzuriaga, K Wu, HL McManus, M Britto, P Borkowsky, W Burchett, S Smith, B Mofenson, L Sullivan, JL

Citation: K. Luzuriaga et al., Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants, J VIROLOGY, 73(1), 1999, pp. 362-367

Authors: McSherry, GD Shapiro, DE Coombs, RW McGrath, N Frenkel, LM Britto, P Culnane, M Sperling, RS

Citation: Gd. Mcsherry et al., The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076), J PEDIAT, 134(6), 1999, pp. 717-724